Table 2 Baseline profile, infected ORIF constructs only

n

31

53

Median age, years (IQR)

55 (45–61)

51 (37–67)

Gender, n (%)

 Male

20 (65)

32 (60)

 Female

11 (35)

21 (40)

Median BMI (IQR)

26.4 (24.2–32.4)

26.9 (23.8–30.3)

Smoker, n (%)

12 (39)

18 (34)

Diabetes mellitus, n (%)

3 (10)

4 (8)

 1

6 (19)

11 (21)

 2

16 (52)

28 (53)

  ≥ 3

7 (23)

12 (23)

 unknown

2 (6)

2 (4)

Infection site

 Lower leg

26 (84)

41 (77)

 Femur

2 (6)

8 (15)

 Upper extremity

3 (10)

4 (8)

Additional IM nail, n (%)

2 (6)

7 (13)

 MSSA

21 (68)

24 (45)

 MRSA

3 (10)

3 (6)

 CNS

2 (6)

11 (21)

 Enterococci

3 (10)

12 (23)

 Streptococci

3 (10)

3 (6)

 E. coli

1

3

 Enterobacter spec.

3

2

 Corynebacter spec.

1

1

 Proteus spec.

0

1

 Pseudomonas spec.

2

2

 Peptostreptococci

0

3

 Klebsiella spec.

0

2

 Candida spec.

0

1

Local gentamicin, n (%)

6 (19)

10 (19)

 Fluoroquinolones

13 (42)

23 (43)

 Rifampicin

8 (26)

15 (28)

 Cefuroxime

6 (19)

14 (26)

 Aminopenicillins

9 (29)

9 (17)

 Clindamycin

2 (6)

5 (9)

 Linezolid

1

1

 Vancomycin

0

2

 Gentamicin

0

2

 Imipenem

1

1

 Tazobactam

1

2

 None

29 (55)

18 (58)

 Any

10 (19)

5 (16)

 Fluoroquinolones and / or rifampicin

14 (26)

8 (26)